These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21388061)
1. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study. Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM Tumori; 2010; 96(6):971-7. PubMed ID: 21388061 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study. Ma W; Deng Y; Zhou L Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921 [TBL] [Abstract][Full Text] [Related]
4. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer. Yamamichi K; Uehara Y; Kitamura N; Nakane Y; Hioki K Int J Cancer; 1998 Jun; 79(3):256-62. PubMed ID: 9645347 [TBL] [Abstract][Full Text] [Related]
7. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance. Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278 [TBL] [Abstract][Full Text] [Related]
8. [The relationship of expression of CD44v6 with metastasis and prognosis in breast cancer]. Deng Y; Ma W; Fang X; Zheng S Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):451-2. PubMed ID: 11832082 [TBL] [Abstract][Full Text] [Related]
9. Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study. Matuschek C; Lehnhardt M; Gerber PA; Poremba C; Hamilton J; Lammering G; Orth K; Budach W; Bojar H; Bölke E; Peiper M Eur J Med Res; 2014 Feb; 19(1):6. PubMed ID: 24491153 [TBL] [Abstract][Full Text] [Related]
10. CD44 splice variants as prognostic markers in colorectal cancer. Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913 [TBL] [Abstract][Full Text] [Related]
11. HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases. Sun H; Liu T; Zhu D; Dong X; Liu F; Liang X; Chen C; Shao B; Wang M; Wang Y Genes Chromosomes Cancer; 2017 Aug; 56(8):598-607. PubMed ID: 28393427 [TBL] [Abstract][Full Text] [Related]
12. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma. Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174 [TBL] [Abstract][Full Text] [Related]
13. The expression of osteopontin in breast cancer tissue and its relationship with p21ras and CD44V6 expression. Gao YL; Xing LQ; Ren TJ; Hou JF; Xue Q; Liu C; Han YM Eur J Gynaecol Oncol; 2016; 37(1):41-7. PubMed ID: 27048108 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery. Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Tan D; Xu K Diagn Pathol; 2013 Sep; 8():146. PubMed ID: 24004467 [TBL] [Abstract][Full Text] [Related]
15. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation. Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088 [TBL] [Abstract][Full Text] [Related]
16. CD44v6 is not a prognostic factor in primary breast cancer. Jansen RH; Joosten-Achjanie SR; Arends JW; Volovics A; Hupperets PS; Schouten HC; Hillen HF Ann Oncol; 1998 Jan; 9(1):109-11. PubMed ID: 9541692 [TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma]. Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753 [TBL] [Abstract][Full Text] [Related]
19. Cytosol concentrations of CD44 isoforms in breast cancer tissue. Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127 [TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours. Imam H; Eriksson B; Oberg K Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]